Kappa agonist-induced reduction in dopamine release: site of action and tolerance.

Donzanti, B A

Kappa agonist-induced reduction in dopamine release: site of action and tolerance. [electronic resource] - Research communications in chemical pathology and pharmacology Nov 1992 - 193-210 p. digital

Publication Type: Journal Article

0034-5164


3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer
3,4-Dihydroxyphenylacetic Acid--metabolism
Analgesics--pharmacology
Animals
Dopamine--metabolism
Drug Tolerance
Homovanillic Acid--metabolism
Hydroxyindoleacetic Acid--metabolism
Male
Nucleus Accumbens--drug effects
Perfusion
Pyrrolidines--pharmacology
Rats
Rats, Sprague-Dawley
Receptors, Opioid, kappa--metabolism